DrugPatentWatch Database Preview

ERGOLOID MESYLATES - Generic Drug Details

What are the generic sources for ergoloid mesylates and what is the scope of ergoloid mesylates freedom to operate?
Ergoloid mesylates is the generic ingredient in eight branded drugs marketed by Novartis, Mutual Pharm, Sun Pharm Industries, Watson Labs, Sandoz, 3M, Bristol Myers Squibb, Kv Pharm, Lederle, Superpharm, Vangard, and Ivax Pharms, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ergoloid mesylates. Two suppliers are listed for this compound.

US Patents:	0
Tradenames:	8
Applicants:	12
NDAs:	34
Drug Master File Entries:	4
Suppliers / Packagers:	2
Clinical Trials:	1
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ERGOLOID MESYLATES
DailyMed Link:	ERGOLOID MESYLATES at DailyMed

Adrenergic alpha-Antagonists
Nootropic Agents
Vasodilator Agents

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kv Pharm	ERGOLOID MESYLATES	ergoloid mesylates	TABLET;SUBLINGUAL	085899-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Ivax Pharms	HYDROGENATED ERGOT ALKALOIDS	ergoloid mesylates	TABLET;SUBLINGUAL	087185-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Watson Labs	ERGOLOID MESYLATES	ergoloid mesylates	TABLET;SUBLINGUAL	084930-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Kv Pharm	ERGOLOID MESYLATES	ergoloid mesylates	TABLET;SUBLINGUAL	086265-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	HYDERGINE LC	ergoloid mesylates	CAPSULE;ORAL	018706-001	Jan 18, 1983	➤ Sign Up	➤ Sign Up
Novartis	HYDERGINE	ergoloid mesylates	SOLUTION;ORAL	018418-001	Approved Prior to Jan 1, 1982	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration